Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,086
Closed -$338K 244
2025
Q1
$338K Sell
1,086
-100
-8% -$29.5K 0.13% 161
2024
Q4
$309K Buy
1,186
+234
+25% +$69.4K 0.11% 175
2024
Q3
$307K Sell
952
-46
-5% -$15K 0.12% 162
2024
Q2
$312K Sell
998
-616
-38% -$181K 0.13% 148
2024
Q1
$459K Buy
1,614
+123
+8% +$36K 0.18% 129
2023
Q4
$429K Buy
1,491
+121
+9% +$33K 0.17% 118
2023
Q3
$368K Buy
1,370
+17
+1% +$4.24K 0.17% 120
2023
Q2
$300K Buy
1,353
+43
+3% +$9.98K 0.13% 158
2023
Q1
$317K Sell
1,310
-76
-5% -$18.7K 0.15% 150
2022
Q4
$364K Sell
1,386
-7
-0.5% -$1.88K 0.17% 125
2022
Q3
$314K Buy
1,393
+82
+6% +$19.9K 0.17% 131
2022
Q2
$319K Sell
1,311
-2
-0.2% -$490 0.17% 132
2022
Q1
$318K Buy
1,313
+6
+0.5% +$1.38K 0.13% 162
2021
Q4
$294K Sell
1,307
-92
-7% -$19.4K 0.12% 185
2021
Q3
$297K Sell
1,399
-2
-0.1% -$460 0.13% 177
2021
Q2
$342K Sell
1,401
-1,529
-52% -$376K 0.08% 180
2021
Q1
$728K Buy
2,930
+110
+4% +$26.2K 0.16% 155
2020
Q4
$648K Buy
2,820
+72
+3% +$16.6K 0.16% 158
2020
Q3
$698K Hold
2,748
0.19% 130
2020
Q2
$648K Sell
2,748
-204
-7% -$46.5K 0.18% 137
2020
Q1
$598K Sell
2,952
-724
-20% -$158K 0.17% 102
2019
Q4
$886K Buy
+3,676
New +$810K 0.23% 97

Other funds holding AMGN

Veracity Capital's AMGN Position: Q2 2025 in Review

Veracity Capital sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,086 shares — an estimated $338K sold.

Veracity Capital first reported a position in AMGN in Q4 2019 and held it in 22 quarters. The position peaked at $886K in Q4 2019. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Veracity Capital reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Veracity Capital sold 1,086 Amgen shares in Q2 2025, an estimated $338K.
  • Veracity Capital first reported a position in Amgen in Q4 2019 and held it in 22 quarters.
  • Veracity Capital's Amgen position peaked at $886K in Q4 2019.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Veracity Capital's 13F filing for Q2 2025, filed 9 Jul 2025.